SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Commentary: Relative treatment effects are consistent across the spectrum of underlying risks … usually
3 references·5 citing·36 second hop
Commentary: Relative treatment effects are consistent across the spectrum of underlying risks … usually (2002)Commentary: Relative treatment effects ar…Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses (2002)Can we individualize the ‘num…An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials (1998)An empirical study of the eff…The relation between treatment benefit and underlying risk in meta-analysis (1996)The relation between treatmen…Frequency of Treatment-Effect Modification Affecting Indirect Comparisons (2010)Frequency of Treatment-Effect…Statistical Analysis of Cost‐effectiveness Data (2006)Statistical Analysis of Cost‐…???Lost in Translation??? (2006)???Lost in Translation???Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities (2005)Both clinical epidemiology an…Numbers needed to treat derived from meta-analysis: a word of caution. (2003)Numbers needed to treat deriv…An Assessment of Clinically Useful Measures of the Consequences of Treatment (1988)Numbers needed to treat derived from meta-analyses---sometimes informative, usually misleading (1999)Systematic Reviews in Health Care (2001)Meta-analysis in clinical trials (1986)Quantifying heterogeneity in a meta‐analysis (2002)Cochrane Handbook for Systematic Reviews of Interventions (2008)How should meta‐regression analyses be undertaken and interpreted? (2002)Combination of direct and indirect evidence in mixed treatment comparisons (2004)Controlling the risk of spurious findings from meta‐regression (2004)Economic evaluation to inform health care decision-making: Promise, pitfalls and a proposal for an alternative path (2011)Health inequalities among British civil servants: the Whitehall II study (1991)THE CONTRIBUTION OF THE SOCIAL ENVIRONMENT TO HOST RESISTANCE: THE FOURTH WADE HAMPTON FROST LECTURE1 (1995)Socioeconomic Factors, Health Behaviors, and Mortality (1998)Meta-Analysis in Clinical Research (1987)A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction (1992)Comparing methods of measurement: why plotting difference against standard method is misleading (1995)Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches (2000)Can meta-analysis help target interventions at individuals most likely to benefit? (2005)Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: case study (2006)QUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1 (1987)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Investigating causes of heterogeneity in systematic reviews (2002)Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary (2005)Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature (2012)Review papers : The statistical basis of meta-analysis (1993)Summing up evidence: one answer is not always enough (1998)Systematic Reviews in Health Care : Meta-Analysis in Context (2000)Reliable change and minimum important difference (MID) proportions facilitated group responsiveness comparisons using individual threshold criteria (2004)Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies (2009)The effects of psychotherapies for depression on response, remission, reliable change, and deterioration: A meta‐analysis (2021)Utility approach to measuring health-related quality of life (1987)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Methods for the Economic Evaluation of Health Care Programmes (2005)Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial (2009)Health Economic Methods: Cost-Minimization, Cost-Effectiveness, Cost-Utility, and Cost-Benefit Evaluations (2011)Probabilistic sensitivity analysis in health economics (2011)
this work references cited by second hop

References

  • 2002Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses318 cited
  • 1998An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials217 cited
  • 1996The relation between treatment benefit and underlying risk in meta-analysis172 cited

Cited by

  • 2006Statistical Analysis of Cost‐effectiveness Data155 cited
  • 2006???Lost in Translation???80 cited
  • 2005Both clinical epidemiology and population health perspectives can define the role of health care in reducing health disparities32 cited
  • 2010Frequency of Treatment-Effect Modification Affecting Indirect Comparisons19 cited
  • 2003Numbers needed to treat derived from meta-analysis: a word of caution.18 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work